glp-1 news today obesity drug updates News: Latest on Weight Loss and Diabetes Medications glp-1 news today obesity drug

So we don't cure it, but we're able to treat it, which actually is like many other chronic diseases: diabetes, asthma, hypertension, high cholesterol

1 Guidelines, manufacturers, and FDA warnings have erred on the side of caution and recommend careful use of GLP-1 RAs in patients with a history or high risk of pancreatitis

Rodrigues T, Borges P, Mar L, et al

Statistical significance was defined as with P value of two-sided test 0.05, Fig

Three-quarters (75%) of users reported cutting back on chocolate consumption, while 72% said they had reduced crisp purchases

Another 2025 survey published in JAMA Health Forum noted that, should Medicare pay for the drugs, it could avoid spending a hypothetical $18.2 billion on obesity-related health expenditures over 10 years while dishing out $65.9 billion annually on the GLP-1s by year 10, thereby negating any savings